DMAAR Key Statistics, Chart & Performance
The current stock price of DMAAR is 0.1599 USD. In the past month the price decreased by -13.33%.
DRUGS MADE IN AMERICA AC-RTS / DMAAR FAQ
What does DMAAR do?
Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.
What is the current price of DMAAR stock?
The current stock price of DMAAR is 0.1599 USD. The price decreased by -0.06% in the last trading session.
How is the ChartMill rating for DRUGS MADE IN AMERICA AC-RTS?
DMAAR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists DMAAR stock?
DMAAR stock is listed on the Nasdaq exchange.